Catherine joined Inserm-Transfert in 2005. She graduated from the Ecole Normal Superieure, Catherine received a Ph.D. in Molecular Virology at the University René Diderot in 1996. She completed her studies mainly in the private sector (pre-doctoral study at Loreal and PhD thesis at Genset). After her thesis, she continued her research on cardiovascular disease in biotechnology companies. She also won the Aventis Foundation for the creation of the company Helios Biosciences and helped set up within the engineering school ESIEA a teaching methodology in bioinformatics and life sciences. She is a regular expert at the European Commission for the People program. Thanks to her job training and experience as project leader in biotech, Catherine has experience with managing international research projects and multidisciplinary. She is fluently bilingual through daily practice of English in their professional activities.
As senior manager of the European project, Catherine Clusel acquired within 7 years of Inserm-Transfert extensive experience installing and managing European projects (FP6 and FP7) and transatlantic (Fondation Leducq) in the field of metabolic and cardiovascular diseases. She participated in the assembly and / or management projects such as: EVGN (FP6-NoE coordinated by Inserm), Florinash (FP7-medium-scale coordinated by INSERM) and MetaCARDIS (FP7-wide scale coordinated by INSERM). Catherine has a unique experience on the installation and management of transatlantic alliances Foundation Leducq (CAPTAA; cycAMP, MITRAL).